{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\n[0009] Accordingly, in one aspect, the present disclosure provides a multi-specific binding protein comprising: (a) a first antigen-binding site that binds human CD 19 with a KD within the range of 5 pM to 1 nM; and (b) a second antigen-binding site that binds human CD3 with a KD within the range of 0.5 nM to 20 nM.\n\n[0011] In certain embodiments, the first antigen-binding site binds human CD 19 with a KD within the range of 5 pM to 0.1 nM, and the second antigen-binding site binds human CD3 with a KD within the range of 0.5 nM to 10 nM.\n\n[0012] In certain embodiments, the first antigen-binding site binds human CD 19 with a KD within the range of 50 pM to 1 nM, and the second antigen-binding site binds human CD3 with a KD within the range of 1 nM to 20 nM.\n\n[0014] In certain embodiments, the antigen-binding site binds human CD 19 with a KD lower than or equal to 1 nM.\n\n[0015] In certain embodiments, the antigen-binding site binds human CD 19 with a KD lower than or equal to 0.3 nM.\n\n[0026] In certain embodiments, the second antigen-binding site binds human CD3s with a KD in the range of 1-100 nM.\n\n[0020] In certain embodiments, the third antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM.\n\n[0020] In certain embodiments, the third antigen-binding site binds protein A with a KD lower than or equal to 2 nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "5 pM to 1 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.5 nM to 20 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "5 pM to 0.1 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.5 nM to 10 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "50 pM to 1 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1 nM to 20 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "less than or equal to 1 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "less than or equal to 0.3 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human CD3s", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-100 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "less than or equal to 10 nM", "unit": null}, {"molecule_name": null, "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "less than or equal to 2 nM", "unit": null}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a specific molecule name, ID, or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "In certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.3", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.3", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.1-0.3", "unit": "nM"}]}
{"raw_mentions": "In certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigenbinding site is present as a monomer."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.2", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.2", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.1-0.2", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": "CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=0.3", "unit": "nM"}, {"molecule_name": "CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.3", "unit": "nM"}, {"molecule_name": "CNG-CD19-101, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=0.2", "unit": "nM"}, {"molecule_name": "CNG-CD19-101, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.2", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=9", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-9", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=8", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-8", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=7", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-7", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=6", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-6", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=5", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-5", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=4", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-4", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=3", "unit": "nM"}, {"molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-3", "unit": "nM"}]}
{"raw_mentions": "In certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "2 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.5 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-2 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-1 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.5 nM", "unit": "nM"}]}
{"raw_mentions": "In certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05-0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.4 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.3 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.2 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.1 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.4 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.3 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.2 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.1 nM", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22642 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22641 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.5 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-2 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-1 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.5 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.4 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.3 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.2 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22640.1 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.4 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.3 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.2 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "human CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.05-0.1 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22648 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22647 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22646 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22645 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22644 nM", "unit": "nM"}, {"molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22643 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-8 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-7 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-6 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-5 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-4 nM", "unit": "nM"}, {"molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710", "protein_target_name": "cynomolgus CD19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-3 nM", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the first antigen-binding site binds CD 19 with a KD lower than or equal to 20 nM, 15 nM, 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, 3 nM, 2 nM, 1 nM, 0.9 nM, 0.8 nM, 0.7 nM, 0.6 nM, 0.5 nM, 0.4 nM, 0.3 nM, 0.2 nM, 0.1 nM, 90 pM, 80 pM, 70 pM, 60 pM, 50 pM, 40 pM, 30 pM, 20 pM, or 10 pM.\nFor example, in certain embodiments, the first antigen-binding site binds CD 19 with a KD about 5 pM - about 1 nM, about 5 pM - about 0.9 nM, about 5 pM - about 0.8 nM, about 5 pM - about 0.7 nM, about 5 pM - about 0.6 nM, about 5 pM nM - about 0.5 nM, about 5 pM - about 0.4 nM, about 5 pM - about 0.3 nM, about 5 pM - about 0.2 nM, about 5 pM - about 0.1 nM, about 5 pM - about 50 pM, about 5 pM - about 20 pM, about 5 pM - to about 10 pM, about 10 pM - about 1 nM, about 10 pM - about 0.9 nM, about 10 pM - about 0.8 nM, about 10 pM - about 0.7 nM, about 10 pM - about 0.6 nM, about 10 pM - about 0.5 nM, about 10 pM - about 0.4 nM, about 10 pM - about 0.3 nM, about 10 pM - about 0.2 nM, about 10 pM - about 0.1 nM, about 10 pM - about 50 pM, about 10 pM - about 20 pM, about 50 pM - about 1 nM, about 50 pM - about 0.9 nM, about 50 pM - about 0.8 nM, about 50 pM - about 0.7 nM, about 50 pM - about 0.6 nM, about 50 pM nM - about 0.5 nM, about 50 pM - about 0.4 nM, about 50 pM - about 0.3 nM, about 50 pM - about 0.2 nM, about 50 pM - about 0.1 nM, about 0.1 nM - about 10 nM, about 0.1 nM - about 9 nM, about 0.1 nM - about 8 nM, about 0.1 nM - about 7 nM, about 0.1 nM - about 6 nM, about 0.1 nM - about 5 nM, about 0.1 nM - about 4 nM, about 0.1 nM - about 3 nM, about 0.1 nM - about 2 nM, about 0.1 nM - about 1 nM, about 0.1 nM - about 0.5 nM, about 0.5 nM - about 10 nM, about 1 nM - about 10 nM, about 2 nM - about 10 nM, about 3 nM - about 10 nM, about 4 nM - about 10 nM, about 5 nM - about 10 nM, about 6 nM - about 10 nM, about 7 nM - about 10 nM, about 8 nM - about 10 nM, or about 9 nM - about 10 nM."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the second antigen-binding site of the multi-specific binding protein binds CD3 (e.g., human CD3 and/or Macaca CD3) with a dissociation constant (KD) of about 0.1 nM - about 1 mM.\nIn certain embodiments, the second antigen-binding site binds CD3 with a KD, as measured by SPR, lower than or equal to 20 nM, 15 nM, 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, 3 nM, 2 nM, 1 nM, 0.9 nM, 0.8 nM, 0.7 nM, 0.6 nM, 0.5 nM, 0.4 nM, 0.3 nM, 0.2 nM, 0.1 nM, 90 pM, 80 pM, 70 pM, 60 pM, 50 pM, 40 pM, 30 pM, 20 pM, or 10 pM.\nIn certain embodiments, the second antigen-binding site binds CD3 with a KD, as measured by BLI, lower than or equal to 50 nM, 40 nM, 30 nM, 20 nM, 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, 3 nM, 2 nM, 1 nM, 0.9 nM, 0.8 nM, 0.7 nM, 0.6 nM, 0.5 nM, 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM.\nIn certain embodiments, the second antigen-binding site binds CD3 (e.g., human CD3, e.g., human CD3s) with a KD, as measured by SPR, greater than or equal to 1 nM, 2 nM, 3 nM, 4 nM, 5 nM, 6 nM, 7 nM, 8 nM, 9 nM, 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, 60 nM, 70 nM, 80 nM, 90 nM, or 100 nM.\nIn certain embodiments, the second antigen-binding site binds CD3 (e.g., human CD3, e.g., human CD3s) with a KD, as measured by BLI, greater than or equal to 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, 60 nM, 70 nM, 80 nM, 90 nM, 100 nM, 200 nM, 300 nM, 400 nM, 500 nM, 600 nM, 700 nM, 800 nM, 900 nM, or 1 mM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "0.1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1", "unit": "mM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<= 20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<= 10", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<= 50", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<= 0.1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">= 1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">= 100", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">= 10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD3", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": ">= 1", "unit": "mM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": "antigen-binding site", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u226410", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-10", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22642.5", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-2.5", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u226410", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "\u22642.5", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-10", "unit": "nM"}, {"molecule_name": "antigen-binding site", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-2.5", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."}
{"final_json": [{"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=10 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-10 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "cynomolgus serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=9 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "cynomolgus serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-9 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "mouse serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=100 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120", "protein_target_name": "mouse serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-100 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=10 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-10 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=2.5 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-2.5 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "<=2.5 nM", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117", "protein_target_name": "protein A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "1-2.5 nM", "unit": "nM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a specific molecule name, ID, or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. \n\nHowever, one sentence comes close but lacks a specific molecule name and a numeric value with a unit:\n\"In certain embodiments, the EC50 value of the multi-specific binding protein for killing CD 19-expressing cells in the presence of serum albumin is increased by no more than 1.5 fold, 2 fold, 3 fold, 4 fold, 5 fold, 6 fold, 7 fold, 8 fold, 9 fold, 10 fold, 15 fold, 20 fold, 25 fold, 30 fold, 35 fold, 40 fold, 45 fold, or 50 fold compared to that in the absence or substantial absence of serum albumin.\"\n\nThis sentence does not meet the criteria because it lacks a specific numeric value with a unit for the EC50 value."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe sensors with loaded IgGs were exposed to 100 nM human serum albumin for 3 minutes, and subsequently transferred to assay buffer for 3 minutes for off-rate measurement.\nCells were then incubated with 100 m\u0390 of 1: 100 Human-PE for 15 minutes on ice.\nAs shown in Table 9, CNG-CD 19- 101 to -110 showed higher binding affinity to human CD 19 and/or cynomolgus CD 19 than CNG-CD 19-1; CNG-CD 19- 103 to -110 bound cynomolgus CD 19 with lower KD values than CNG-CD 19-1.\nCNG-CD 19-101 to - 109 bound human CD 19 with lower KD values than CNG-CD 19-1; \nThe scFv proteins were serially diluted and assessed at 25\u00b0 C in a HBS-EP+ running buffer system (10 mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.05% Surfactant P20) using a Biacore 8K optical biosensor (Global Life Sciences Solutions USA, Marlborough, MA).\nThis was followed by an injection (300 s at 4.0 pL/min) of biotinylated CD-19 (40 nM) overflow cell 2.\nTest scFvs (16.2 to 0.067 nM, 3 -fold dilution in running buffer) was injected (300 s at 30 uL/min) over flow cells 1 and 2."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "100", "unit": "nM"}, {"molecule_name": "Human-PE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "100", "unit": "m\u0390"}, {"molecule_name": "CNG-CD 19-101 to -110", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "CNG-CD 19-103 to -110", "protein_target_name": "cynomolgus CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "CNG-CD 19-101 to -109", "protein_target_name": "human CD 19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "biotinylated CD-19", "protein_target_name": "CD-19", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "40", "unit": "nM"}, {"molecule_name": "scFvs", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "16.2", "unit": "nM"}, {"molecule_name": "scFvs", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.067", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe sensors with loaded HCAbs were exposed to 100 nM human serum albumin for 3 minutes, and subsequently transferred to assay buffer for 3 minutes for off-rate measurement.\nCNG-HSA-101, CNG-HSA-103, CNG-HSA-106, CNG-HSA-107, CNG-HSA-108, CNG-HSA-109, CNG-HSA-111, CNG-HSA-113, CNG-HSA-114, CNG-HSA-115, CNG-HSA-116, CNG-HSA-118, and CNG-HSA-120 bound mouse serum albumin with a KD value less than 4-fold higher than the KD with which the same antibody bound human serum albumin."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "100", "unit": "nM"}, {"molecule_name": "CNG-HSA-101, CNG-HSA-103, CNG-HSA-106, CNG-HSA-107, CNG-HSA-108, CNG-HSA-109, CNG-HSA-111, CNG-HSA-113, CNG-HSA-114, CNG-HSA-115, CNG-HSA-116, CNG-HSA-118, CNG-HSA-120", "protein_target_name": "mouse serum albumin", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": "< 4-fold higher than the KD with which the same antibody bound human serum albumin", "unit": null}]}
